Jump to navigation
The ADAPT Study is exploring the impacts of COVID-19 on Australians who use illicit drugs.
The Climate and Preventure (CAP) long-term follow up is an opportunistic extension of the landmark CAP study, whereby fo
Behavioural and pharmacological approaches to smoking cessation are effective at helping people to quit but long-term quit rates remain low, especi
This project aims to improve access for Aboriginal and Torres Strait Islander people to culturally appropriate, evidence‐based information about ice.
NDRI will lead a multi-site NHMRC-funded world-first trial of a promising new medication for dependence on ice.
This project aims to investigate impediments to uptake of ‘take-home’ naloxone in Australia.
This project will investigate the social practices associated with men’s use of performance and image enhancing drugs
This project will review the evidence for the medicinal use of cannabis and cannabinoid products for a number of key medical conditions.
Substance use among pregnant women is a significant public health issue.
This innovative study aims to contribute significantly to our understanding of methamphetamines in Aboriginal community contexts.
This study aims to extend the period of abstinence created by the NT prison-smoking ban into the community.
The national centres are supported by funding from the Australian Government under the Drug and Alcohol Program
Page last updated: Wednesday 20 May 2020